I. Rooms, K. Dujardin, D. Sutter, and J. , Non-compaction cardiomyopathy: a genetically and clinically heterogeneous disorder, Acta Cardiol, vol.70, pp.625-656, 2015.

J. Finsterer, Cardiogenetics, Neurogenetics, and Pathogenetics of Left Ventricular Hypertrabeculation/Noncompaction, Pediatric Cardiology, vol.26, issue.5, pp.659-81, 2009.
DOI : 10.1007/s00246-008-9359-0

V. Jordan, H. Zaveri, and D. Scott, 1p36 deletion syndrome: an update, Appl Clin Genet, vol.8, pp.189-200, 2015.

J. Finsterer and S. Zarrouk-mahjoub, Considerations about the genetics of left ventricular hypertrabeculation/non-compaction, Cardiology in the Young, vol.25, issue.07, pp.1435-1442, 2015.
DOI : 10.1080/14017430701744451

C. Stöllberger, J. Finsterer, and G. Blazek, Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders, The American Journal of Cardiology, vol.90, issue.8
DOI : 10.1016/S0002-9149(02)02723-6

. Or-hyper-ck-aemia, Because of this association, we repeatedly recommended to screen all LVHT patients for NMD. NMD in LVHT patients may be subtle or subclinical and LVHT may be the initial manifestation of the NMD. Overall, these interesting cases should be more broadly examined as outlined above to contribute to the elucidation of the still enigmatic background of LVHT, CONFLICT OF INTEREST: none